Efficacy of induced luteinizing hormone surge after “trigger” with gonadotropin-releasing hormone agonist
Authors:
- Said T. DaneshmandSDSaid T. Daneshmand
- Humberto RestrepoHRHumberto Restrepo
- Forest C. GarnerFGForest C. Garner
- Martha AguirreMAMartha Aguirre
- Cynthia HudsonCHCynthia Hudson
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (2) , 826-828
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind studyReproductive BioMedicine Online, 2009
- Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilizationFertility and Sterility, 2008
- The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled studyFertility and Sterility, 2008
- Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilizationFertility and Sterility, 2005
- Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndromeFertility and Sterility, 2004
- Ovarian hyperstimulation syndromeFertility and Sterility, 2003
- Endocrine Profiles after Triggering of Final Oocyte Maturation with GnRH Agonist after Cotreatment with the GnRH Antagonist Ganirelix during Ovarian Hyperstimulation forin VitroFertilizationThe Journal of Clinical Endocrinology & Metabolism, 2002